Comparison Between ER Loss and Triple-Negative Breast Cancer Guided by 18F-FES PET/CT in Metastatic Breast Cancer

Early Interim 18F-FDG-PET and 18F-FLT-PET for Predicting Treatment Response and Survival in Metastatic Breast Cancer

NCT04411966 ·Status: COMPLETED ·Phase: NA

Characterizing Breast Cancer With 18F-FES PET/CT

NCT05613270 ·Status: UNKNOWN ·Phase: NA

The Value of 18F-FES-PET/CT in Predicting Fulvestrant Efficacy in Breast Cancer

NCT03768479 ·Status: UNKNOWN ·Phase: NA

[18F]FES PET/CT for the Detection of Distant Metastasis in Low-grade ER-positive Stage III Breast Cancer

NCT07314073 ·Status: RECRUITING ·Phase: PHASE2

The Use of FES-PET Imaging as a Tool to Detect a Possible Reversion of Estrogen Receptor (ER)-α Status in Patients With Metastatic Breast Cancer HER2 + and ERα Neg Treated With Trastuzumab + Pertuzumab + Taxane.

NCT03619044 ·Status: TERMINATED ·Phase: NA

Study to Determine the Utility of FES-PET in the Prediction of Response to Fulvestrant in Women With Estrogen Positive Metastatic Breast Cancer

NCT03507088 ·Status: COMPLETED ·Phase: NA

Estrogen Receptor (ER) PET/CT Imaging in Breast Cancer

NCT05541367 ·Status: RECRUITING

Fluoroestradiol PET Imaging in Predicting Response to Hormone Therapy of Breast Cancer

NCT01627704 ·Status: COMPLETED ·Phase: NA

Prediction of 18F-FES-PET/CT Parameters on Palbociclib Combined With ET

NCT04992156 ·Status: COMPLETED

[18F]-DPA-714 PET/CT (Positron Emission Tomography/Computerized Tomography) in Triple Negative Breast Cancers

NCT04320030 ·Status: COMPLETED ·Phase: PHASE2

Diagnostic Accuracy and Safety Study of FES PET/CT in Assessment of ER Status of Recurrent or Metastatic Breast Cancer

NCT01986569 ·Status: COMPLETED ·Phase: PHASE3

Diagnostic Performance of [18F]FES PET/CT for Axillary LN Metastasis in ER-positive Breast Cancer

NCT06695039 ·Status: COMPLETED ·Phase: PHASE2

Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation

NCT03544762 ·Status: UNKNOWN ·Phase: PHASE3

4FMFES-PET Imaging of ER+ Advanced Breast Cancers

NCT04824014 ·Status: RECRUITING ·Phase: PHASE2

A Study Comparing Cancer Imaging Approaches in People With Lobular Breast Cancer

NCT06557148 ·Status: RECRUITING

Breast PET Feasibility

NCT03198442 ·Status: COMPLETED ·Phase: NA

FDG PET-CT in Advanced Breast Cancer

NCT07173868 ·Status: RECRUITING

Relationship Between Hypoxia and Endocrine Response in Human Breast Cancer

NCT01814449 ·Status: UNKNOWN

The Prognostic Value of FDG PET/CT and Diffusion-weighed Imaging on Breast Cancer

NCT01942759 ·Status: COMPLETED

Prediction of Response to 2nd-line Hormone Therapy by FES CT/PET in Patients With Metastatic Breast Cancer

NCT03442504 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

PET/CT Guided Fulvestrant Therapy for Patients With Recurrent or Metastatic Breast Cancer

NCT00816582 ·Status: TERMINATED ·Phase: NA

18F-FDG Versus 68Ga-FAPI-46 as PET Tracer in ER-positive Breast Cancer.

NCT06335069 ·Status: RECRUITING ·Phase: PHASE2

Evaluation of the Unconformity of the Hormonal Status of Metastatic Lesions During a First Relapse of Breast Cancer Initially Expressing Estrogen Receptors: a Pilot Study on the Interest of PET With FES

NCT03873428 ·Status: RECRUITING ·Phase: NA

18F-FDG PET Metabolic Phenotype in Evaluating Therapeutic Response for Breast Cancer Patients With Bone Metastases.

NCT01927939 ·Status: UNKNOWN

Dynamic Observational Study With PET of 68Ga-HER2-affibody in Anti-HER2 Treatment

NCT04769050 ·Status: UNKNOWN